医药生物行业2025年10月投资策略:看好创新药长期逻辑 关注底部反转标的

国信证券
Oct 23

多项成果在ESMO中展示。2025年的欧洲肿瘤学会(ESMO)将于10月中下旬举行,一系列国产创新药的研究成果在会议中进行展示:康方生物的伊沃西联合化疗对照替雷利珠单抗联合化疗一线治疗sqNSCLC的ph3临床(HARMONi-6),科伦博泰的sac-TMT单药对照含铂双药化疗二线治疗EGFRm NSCLC的ph3临床(OptiTROP-Lung04),sac-TMT单药对照化疗治疗HR+/...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10